TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 161 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$464
-33.0%
40,431
+47.6%
0.01%
-28.6%
Q2 2023$693
-34.9%
27,384
-17.2%
0.01%
-36.4%
Q1 2023$1,065
+25.1%
33,062
-28.3%
0.01%
+22.2%
Q4 2022$851
-99.7%
46,089
+127.0%
0.01%
+200.0%
Q4 2021$331,000
-41.5%
20,3020.0%0.00%
-40.0%
Q3 2021$566,000
-51.1%
20,302
-48.0%
0.01%
-54.5%
Q2 2021$1,157,000
+6.0%
39,0210.0%0.01%0.0%
Q1 2021$1,091,000
-6.7%
39,021
-5.4%
0.01%
-8.3%
Q4 2020$1,169,000
+40.3%
41,254
+24.5%
0.01%
+33.3%
Q3 2020$833,000
+3.0%
33,1310.0%0.01%
-10.0%
Q2 2020$809,000
+65.1%
33,1310.0%0.01%
+42.9%
Q1 2020$490,000
-8.9%
33,1310.0%0.01%
+16.7%
Q4 2019$538,000
+24.8%
33,1310.0%0.01%
+20.0%
Q3 2019$431,000
+0.2%
33,1310.0%0.01%0.0%
Q2 2019$430,000
-17.6%
33,1310.0%0.01%
-16.7%
Q1 2019$522,000
+7.9%
33,131
+37.9%
0.01%
-14.3%
Q4 2018$484,000
+18.6%
24,030
+46.3%
0.01%
+40.0%
Q3 2018$408,000
-15.9%
16,423
-7.1%
0.01%
-16.7%
Q2 2018$485,000
+11.8%
17,678
+25.4%
0.01%
+20.0%
Q1 2018$434,000
-13.9%
14,1000.0%0.01%
-16.7%
Q4 2017$504,00014,1000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$121,230,00021.92%
Rhenman & Partners Asset Management AB 220,000$5,808,0000.83%
ArrowMark Colorado Holdings LLC 2,045,862$54,011,0000.67%
Vivo Capital, LLC 77,373$2,043,0000.52%
Ghost Tree Capital, LLC 89,295$2,357,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 124,932$3,298,0000.47%
Polar Capital LLP 1,296,371$34,220,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 70,095$1,851,0000.24%
EAM Investors, LLC 33,897$895,0000.15%
PointState Capital LP 438,200$11,568,0000.13%
View complete list of REVANCE THERAPEUTICS INC shareholders